Your browser doesn't support javascript.
loading
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Santin, Alessandro D; Vergote, Ignace; González-Martín, Antonio; Moore, Kathleen; Oaknin, Ana; Romero, Ignacio; Diab, Sami; Copeland, Larry J; Monk, Bradley J; Coleman, Robert L; Herzog, Thomas J; Siegel, Jonathan; Kasten, Linda; Schlicker, Andreas; Schulz, Anke; Köchert, Karl; Walter, Annette O; Childs, Barrett H; Elbi, Cem; Bulat, Iurie.
Afiliação
  • Santin AD; Yale School of Medicine, New Haven, CT, USA alessandro.santin@Yale.edu.
  • Vergote I; University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • González-Martín A; Clinica Universidad de Navarra, Madrid, Spain.
  • Moore K; University of Oklahoma Health Sciences Center, Oklahoma, OK, USA.
  • Oaknin A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Romero I; Instituto Valenciano de Oncología, Valencia, Spain.
  • Diab S; University of Colorado Cancer Center, Aurora, CO, USA.
  • Copeland LJ; Ohio State University Medical Center, Columbus, OH, USA.
  • Monk BJ; HonorHealth Research Institute, University of Arizona, Phoenix, AZ, USA.
  • Coleman RL; US Oncology Research, Houston, TX, USA.
  • Herzog TJ; University of Cincinnati Cancer Center, Cincinnati, OH, USA.
  • Siegel J; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA.
  • Kasten L; Syneos Health Inc, Morrisville, NC, USA.
  • Schlicker A; Bayer AG, Berlin, Germany.
  • Schulz A; Bayer AG, Berlin, Germany.
  • Köchert K; Bayer AG, Berlin, Germany.
  • Walter AO; Bayer AG, Berlin, Germany.
  • Childs BH; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA.
  • Elbi C; Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, USA.
  • Bulat I; ARENSIA Exploratory Medicine, Institute of Oncology Unit, Chisinau, Moldova.
Int J Gynecol Cancer ; 33(4): 562-570, 2023 04 03.
Article em En | MEDLINE | ID: mdl-36564099

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Imunoconjugados Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Imunoconjugados Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article